Bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapy

Immunotherapy is a promising strategy for nasopharyngeal carcinoma (NPC), a common and aggressive malignancy with poor prognosis. However, the literature lacks a comprehensive and objective overview of the current research status and trends of immunotherapy-related fields in NPC. We performed a bibl...

Full description

Saved in:
Bibliographic Details
Main Authors: Gang Wang, Xiaosu Zou, Jingjin Weng, Guiping Lan, Min Li, Jiazhang Wei, Wenqian Nong, Qicong Chen, Weiwei Miao, Honglin Luo, Shenhong Qu
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2360341
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850238831798779904
author Gang Wang
Xiaosu Zou
Jingjin Weng
Guiping Lan
Min Li
Jiazhang Wei
Wenqian Nong
Qicong Chen
Weiwei Miao
Honglin Luo
Shenhong Qu
author_facet Gang Wang
Xiaosu Zou
Jingjin Weng
Guiping Lan
Min Li
Jiazhang Wei
Wenqian Nong
Qicong Chen
Weiwei Miao
Honglin Luo
Shenhong Qu
author_sort Gang Wang
collection DOAJ
description Immunotherapy is a promising strategy for nasopharyngeal carcinoma (NPC), a common and aggressive malignancy with poor prognosis. However, the literature lacks a comprehensive and objective overview of the current research status and trends of immunotherapy-related fields in NPC. We performed a bibliometric analysis of 513 original articles and reviews in English on immunotherapy for NPC from the Web of Science Core Collection database, using CiteSpace and Bibliometrix software tools. We visualized the development trend of publications, the distribution of countries/regions, the co-occurrence of keywords, the collaboration and citation of authors, the citation of journals, the evolution of topics, and the thematic map. We found that the publication volume increased sharply after 2017, with China as the main contributor and leader, the US as an important partner, and the Netherlands as a potential innovator. The research focused on immune checkpoint inhibitors and cell therapy, which were also the hotspots of clinical trials. Tumor microenvironment, immune infiltration, multicenter studies, and novel immunotherapy were the frontier topics and the key challenges for future research. CD137l-DC, lymphoma, and chimeric antigen receptor were emerging topics with good prospects. Our study provides a valuable insight into the research status and trends of immunotherapy for NPC, which may guide future research directions and clinical applications.
format Article
id doaj-art-48972a49fb4e47608495a2170e88a494
institution OA Journals
issn 2164-5515
2164-554X
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj-art-48972a49fb4e47608495a2170e88a4942025-08-20T02:01:20ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2024-12-0120110.1080/21645515.2024.2360341Bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapyGang Wang0Xiaosu Zou1Jingjin Weng2Guiping Lan3Min Li4Jiazhang Wei5Wenqian Nong6Qicong Chen7Weiwei Miao8Honglin Luo9Shenhong Qu10Institute of Oncology, Guangxi Academy of Medical Sciences, Nanning, Guangxi, ChinaInstitute of Oncology, Guangxi Academy of Medical Sciences, Nanning, Guangxi, ChinaDepartment of Otolaryngology & Head and Neck, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, ChinaDepartment of Otolaryngology & Head and Neck, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, ChinaDepartment of Otolaryngology & Head and Neck, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, ChinaDepartment of Otolaryngology & Head and Neck, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, ChinaInstitute of Oncology, Guangxi Academy of Medical Sciences, Nanning, Guangxi, ChinaInstitute of Oncology, Guangxi Academy of Medical Sciences, Nanning, Guangxi, ChinaInstitute of Oncology, Guangxi Academy of Medical Sciences, Nanning, Guangxi, ChinaInstitute of Oncology, Guangxi Academy of Medical Sciences, Nanning, Guangxi, ChinaInstitute of Oncology, Guangxi Academy of Medical Sciences, Nanning, Guangxi, ChinaImmunotherapy is a promising strategy for nasopharyngeal carcinoma (NPC), a common and aggressive malignancy with poor prognosis. However, the literature lacks a comprehensive and objective overview of the current research status and trends of immunotherapy-related fields in NPC. We performed a bibliometric analysis of 513 original articles and reviews in English on immunotherapy for NPC from the Web of Science Core Collection database, using CiteSpace and Bibliometrix software tools. We visualized the development trend of publications, the distribution of countries/regions, the co-occurrence of keywords, the collaboration and citation of authors, the citation of journals, the evolution of topics, and the thematic map. We found that the publication volume increased sharply after 2017, with China as the main contributor and leader, the US as an important partner, and the Netherlands as a potential innovator. The research focused on immune checkpoint inhibitors and cell therapy, which were also the hotspots of clinical trials. Tumor microenvironment, immune infiltration, multicenter studies, and novel immunotherapy were the frontier topics and the key challenges for future research. CD137l-DC, lymphoma, and chimeric antigen receptor were emerging topics with good prospects. Our study provides a valuable insight into the research status and trends of immunotherapy for NPC, which may guide future research directions and clinical applications.https://www.tandfonline.com/doi/10.1080/21645515.2024.2360341Nasopharyngeal carcinomaimmunotherapybibliometric analysisimmune checkpoint inhibitorstumor microenvironment
spellingShingle Gang Wang
Xiaosu Zou
Jingjin Weng
Guiping Lan
Min Li
Jiazhang Wei
Wenqian Nong
Qicong Chen
Weiwei Miao
Honglin Luo
Shenhong Qu
Bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapy
Human Vaccines & Immunotherapeutics
Nasopharyngeal carcinoma
immunotherapy
bibliometric analysis
immune checkpoint inhibitors
tumor microenvironment
title Bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapy
title_full Bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapy
title_fullStr Bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapy
title_full_unstemmed Bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapy
title_short Bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapy
title_sort bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapy
topic Nasopharyngeal carcinoma
immunotherapy
bibliometric analysis
immune checkpoint inhibitors
tumor microenvironment
url https://www.tandfonline.com/doi/10.1080/21645515.2024.2360341
work_keys_str_mv AT gangwang bibliometricanalysisrevealstheresearchhotspotsandtrendsofnasopharyngealcarcinomaimmunotherapy
AT xiaosuzou bibliometricanalysisrevealstheresearchhotspotsandtrendsofnasopharyngealcarcinomaimmunotherapy
AT jingjinweng bibliometricanalysisrevealstheresearchhotspotsandtrendsofnasopharyngealcarcinomaimmunotherapy
AT guipinglan bibliometricanalysisrevealstheresearchhotspotsandtrendsofnasopharyngealcarcinomaimmunotherapy
AT minli bibliometricanalysisrevealstheresearchhotspotsandtrendsofnasopharyngealcarcinomaimmunotherapy
AT jiazhangwei bibliometricanalysisrevealstheresearchhotspotsandtrendsofnasopharyngealcarcinomaimmunotherapy
AT wenqiannong bibliometricanalysisrevealstheresearchhotspotsandtrendsofnasopharyngealcarcinomaimmunotherapy
AT qicongchen bibliometricanalysisrevealstheresearchhotspotsandtrendsofnasopharyngealcarcinomaimmunotherapy
AT weiweimiao bibliometricanalysisrevealstheresearchhotspotsandtrendsofnasopharyngealcarcinomaimmunotherapy
AT honglinluo bibliometricanalysisrevealstheresearchhotspotsandtrendsofnasopharyngealcarcinomaimmunotherapy
AT shenhongqu bibliometricanalysisrevealstheresearchhotspotsandtrendsofnasopharyngealcarcinomaimmunotherapy